Rx Rebating Bills In House, Senate Come Into Alignment As Passage Likely Punted to 2024

Legislation to delink PBM payments from drug prices advances in House Energy and Commerce health subcommittee, putting a key pharma priority closer to the finish line. Whether patients will see any benefit remains a worry.

runners close to finish line
PBM reform getting closer to finish line in both House and Senate • Source: Shutterstock

The House and Senate proposals to reform the pharmacy benefits management industry are looking more alike following a House Energy and Commerce health subcommittee markup this month, but prospects for 2023 clearance of this legislation is looking increasingly slim.

The House Energy and Commerce health subcommittee easily advanced a handful of PBM policies on 15 November, including a bill...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Pink Sheet